Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06279897 · ClinicalTrials.gov registry record · NA

LBNP Tolerance With Skin Warming After Exercise Cold Stress

A NA study of Blood Pressure and Blood Loss, sponsored by University of Colorado, Colorado Springs.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06279897: Active NA study of Blood Pressure and Blood Loss, sponsored by University of Colorado, Colorado Springs.

NCT06279897 is a NA study of Blood Pressure and Blood Loss that is active but no longer recruiting, run by University of Colorado, Colorado Springs. The registered enrollment target is 10 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06279897, a NA study of Blood Pressure and Blood Loss, is active but no longer recruiting, sponsored by University of Colorado, Colorado Springs.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Assess the effect of skin rewarming during lower body negative pressure upon arterial blood pressure and tolerance to simulated blood loss after exercise in the cold.

Primary Outcome

During simulated blood loss is the reduction in arterial blood pressure greater with progressive skin heating

Interventions

  • OTHER Skin Surface Rewarming
  • OTHER Skin Surface Warming
  • OTHER Skin Surface Heating
  • OTHER Skin Surface Cooling

Study Locations (1)

Colorado

  • University of Colorado Colorado Springs - Colorado Springs

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-01-24
Est. Completion 2026-09-30
Phase NA

What the registry record for NCT06279897 still lists

NCT06279897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 4 interventions - of which Skin Surface Rewarming is the first listed.

NCT06279897 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06279897 about?

NCT06279897 is a clinical study titled "LBNP Tolerance With Skin Warming After Exercise Cold Stress". Assess the effect of skin rewarming during lower body negative pressure upon arterial blood pressure and tolerance to simulated blood loss after exercise in the cold.

What is the current status of trial NCT06279897?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-01-24. Estimated completion is 2026-09-30.

What conditions does trial NCT06279897 study?

This clinical trial studies the following conditions: Blood Pressure, Blood Loss.

What interventions are being tested in trial NCT06279897?

The interventions under investigation include: Skin Surface Rewarming (OTHER), Skin Surface Warming (OTHER), Skin Surface Heating (OTHER), Skin Surface Cooling (OTHER).

Who is sponsoring clinical trial NCT06279897?

This trial is sponsored by University of Colorado, Colorado Springs, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06279897 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06279897's enrollment target sits among peer trials

10 97th of 101 higher than 3 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06279897, the US trial registry maintained by the National Library of Medicine. NCT06279897 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.